Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights GlobeNewswire November 13, 2025 Presented new data at the Society of Immunotherapy for Cancer (SITC) annual meeting on CLD-401 protection from immune clearance after systemic administration; data also demonstrates that the platform can effectively express genetic medicines at the tumor site Established new […]